Internet Stroke Center Home Stroke Trials Registry
 
National Institute of Neurological Disorders & Stroke
American Stroke Association
Washington University School of Medicine
 
Trials Directories
Ongoing Trials
Completed Trials
Acute Stroke Trials
Hemorrhage Trials
Prevention Trials
Recovery Trials
Interventions
Drugs - By Name
Drugs - By Category
Procedures
Recovery Therapies
Assessment Scales
Specific Stroke Scales
Stroke Scales Overview
Stroke Trial Links
Government Sites
Independent Sites
News & Updates
Update List
General Stroke News
About this Site
Submit Your Trial
Send Feedback
Search for Trials
PubMed
We comply with the "Health on the Net" (HON) code of standards for trustworthy health information: verify here.



 
Stroke Interventions in Clinical Trials
Printable Version
Nortriptyline
Pamelor Aventyl

Action
(theoretical) Nortriptyline, a tricyclic antidepressant, blocks the reuptake of norepinephrine and serotonin in the central nervous system. Like all secondary-amine tricyclics, nortriptyline blocks norepinephrine more strongly than it does serotonin.

Status

Trial(s)
  = Ongoing
  = Completed

Fluoxetine vs. Nortriptyline in preventing post-stroke depression
Nortriptyline Treatment of Post-Stroke Depression

Web Links and Publications
Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up.
J Nerv Ment Dis 2002 May;190(5):296-303

UID: 183

   

Internet Stroke Center at Washington University:
HOME | ABOUT | PRIVACY POLICY | CONTACT

Copyright © 1997-2009 - Internet Stroke Center. All rights reserved.                                           Last modified: Friday, November 20, 2009